OUR PIPELINE

OUR PIPELINE

Driving Innovation: ViiV Healthcare's Long‑Acting Pipeline

Assets in development target multiple stages of the HIV life cycle with expanded dosing options

View the ViiV Pipeline Bibliography

VIEW INTERACTIVE PIPELINE
ViiV Healthcare Medical Pipeline
1

Binding and Fusion1

Lotivibart (VH3810109)
Class: bNAb
Phase IIb

2

Nuclear Entry & Uncoating2,3

VH4011499
Class: Capsid inhibitor
Phase II

VH4770359
Class: Capsid inhibitor
Phase I

3

Integration4-8

CAB 1600
Class: INSTI
Phase II (PrEP)
Phase III (Treatment)

VH4524184
Class: INSTI
Phase II

VH4367310
Class: INSTI
Phase I

4

Assembly and Budding2,3

VH4011499
Class: Capsid inhibitor
Phase II

VH4770359
Class: Capsid inhibitor
Phase I

Pipeline image 00
  1. Rolle et al. CROI 2026; Denver, CO. Oral presentation 178.
  2. Thakkar et al. CROI 2026; Denver, CO. Oral presentation 175.
  3. NCT07525544. Available at: https://clinicaltrials.gov. Accessed August 2026
  4. Castronova et al. CROI 2026; Denver, CO. Poster 495.
  5. Han et al. CROI 2024; Denver, CO. Oral Presentation 130.
  6. Back et al. CROI 2026; Denver, CO. Oral Presentation 176.
  7. Baker M et al. AIDS 2024; Poster WEPEA028.
  8. NCT07818915. Available at: https://clinicaltrials.gov. Accessed September 2026.

 

Figure adapted from: ViiV Healthcare meet the management: Getting ahead of HIV together, 2023